improvement of heart failure by human amniotic mesenchymal stromal cell transplantation in rats

Authors

seyed mohammad taghi razavi tousi 1-department of physiology, school of medicine, tehran university of medical sciences, tehran, iran. 2-medical biotechnology research center, guilan university of medical sciences, rasht, iran.

mahdieh faghihi department of physiology, school of medicine, tehran university of medical sciences, tehran, iran.

maliheh nobakht physiology research center, iran university of medical sciences, tehran, iran.

mohammad molazem department of veterinary diagnostic imaging, faculty of veterinary medicine, university of tehran, tehran, iran.

abstract

background: recently, stem cells have been considered for the treatment of heart diseases, but no marked improvement has been recorded. this is the first study to examine the functional and histological effects of the transplantation of human amniotic mesenchymal stromal cells (hamscs) in rats with heart failure (hf). methods: this study was conducted in the years 2014 and 2015. 35 male wistar rats were randomly assigned into 5 equal experimental groups (7 rats each) as 1- control 2- heart failure (hf) 3- sham 4- culture media 5- stem cell transplantation (sct). heart failure was induced using 170 mg/kg/d of isoproterenol subcutaneously injection in 4 consecutive days. the failure confirmed by the rat cardiac echocardiography on day 28. in sct group, 3×10 6 cells in 150 µl of culture media were transplanted to the myocardium. at the end, echocardiographic and hemodynamic parameters together with histological evaluation were done. results: echocardiography results showed that cardiac ejection fraction in hf group increased from 58/73 ± 9% to 81/25 ± 6/05% in sct group (p value < 0.001). fraction shortening in hf group was increased from 27/53 ± 8/58% into 45/55 ± 6/91% in sct group (p value < 0.001). furthermore, hamscs therapy significantly improved mean diastolic blood pressure, mean arterial pressure, left ventricular systolic pressure, rate pressure product, and left ventricular end-diastolic pressure compared to those in the hf group, with the values reaching the normal levels in the control group. a marked reduction in fibrosis tissue was also found in the sct group (p value < 0.001) compared with the animals in the hf group. conclusion: the transplantation of hamscs in rats with heart failure not only decreased the level of fibrosis but also conferred significant improvement in heart performance in terms of echocardiographic and hemodynamic parameters.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Improvement of Heart Failure by Human Amniotic Mesenchymal Stromal Cell Transplantation in Rats

Background: Recently, stem cells have been considered for the treatment of heart diseases, but no marked improvement has been recorded. This is the first study to examine the functional and histological effects of the transplantation of human amniotic mesenchymal stromal cells (hAMSCs) in rats with heart failure (HF). Methods: This study was conducted in the years 2014 and 2015. 35 male Wistar ...

full text

Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats

Objective(s): Heart failure (HF) is one of the leading causes of death worldwide. Due to beneficial effects of stem cells, paracrine secretion of them has recently been used by researchers. The purpose of this study was to investigate the effects of intravenous injection (IV) of conditioned medium (CM) of human amniotic membrane-derived mesenchymal stem cell (MSC-CM) o...

full text

Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia

Introduction. Amniotic membrane contains a multipotential stem cell population and is expected to possess the machinery to regulate immunological reactions. We investigated the safety and efficacy of allogeneic amniotic membrane-derived mesenchymal stromal cell (AMSC) transplantation in a porcine model of chronic myocardial ischemia as a preclinical trial. Methods. Porcine AMSCs were isolated f...

full text

Effects of human amnion-derived mesenchymal stromal cell transplantation in rats with radiation proctitis.

BACKGROUND AIMS Mesenchymal stromal cells (MSCs) have been reported to be a promising cell source in cell therapy, and large amounts of MSCs can easily be isolated from human amnion. Therapeutic irradiation for intra-pelvic cancer often causes radiation proctitis; however, there is currently no effective treatment. We therefore investigated the effect of transplantation of human amnion-derived ...

full text

Evaluation of intravenous injection of amniotic membrane stem cells to reduce inflammatory factors in heart failure

Background: Heart failure is one of the most common cardiovascular disorders and is considered a chronic, progressive and debilitating disorder. The medical treatment of this disease is accompanied by many problems. Today, stem cells are being used increasingly to reduce the problems of heart failure treatments. Since pro-inflammatory cytokines play an important role in the prognosis and progre...

full text

Recombinant human brain natriuretic peptide therapy combined with bone mesenchymal stem cell transplantation for treating heart failure in rats.

This study aimed to investigate the effects of combined recombinant human brain natriuretic peptide (rhBNP) therapy and bone mesenchymal stem cell (BMSC) transplantation on cell survival in myocardial tissues and on heart function in a rat model of heart failure (HF). Rat BMSCs were isolated, amplified and adherent cultured in vitro. A rat model of HF was established via the intraperitoneal inj...

full text

My Resources

Save resource for easier access later


Journal title:
the journal of tehran university heart center

جلد ۱۱، شماره ۳، صفحات ۱۲۳-۱۳۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023